Breast Cancer Clinical Trial

Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers

Summary

Other than optimizing medical management of cardiac risk factors, and reducing radiotherapy (RT) dose to the heart, there currently exist no interventions to mitigate or reverse the adverse cardiac effects of RT. Aerobic exercise has been demonstrated to improve patient quality of life, cardiac outcomes, and cardiorespiratory fitness in patients with cancer receiving cardiotoxic systemic therapies, but the effects of aerobic exercise on patients at high risk for radiation induced heart disease (RIHD) is unknown. In addition, home-based cardiac rehabilitation has not been tested in patients with thoracic cancers.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Pathologically confirmed or radiographically diagnosed non-small cell lung cancer, small cell lung cancer, esophageal cancer, Hodgkin lymphoma, non-Hodgkin lymphoma, sarcoma, thymoma, or left-sided breast cancer.
Planning to receive neo-adjuvant, adjuvant, or definitive radiation therapy to the thorax with curative intent.
Willing to participate in home-based cardiac rehabilitation program and be monitored remotely via smart phone application
Possess a smart phone or tablet capable of supporting teleHeart application
Willing and eligible to co-enroll in the Cardiovascular Toxicity in Cancer and Improvement in Recovery (SURVIVE) Registry Study (HRPO# 201801031).
At least 18 years of age.
ECOG performance status ≤ 2
Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).

Exclusion Criteria:

Presence of distant metastatic disease (except patients with lymphoma).
Life expectancy less than 6 months
Patient lives in skilled nursing facility, chronic care facility, nursing home, or palliative care or hospice facility
Unable to walk
Presence of significant cancer disease burden that would make patient unlikely to tolerate cardiac rehabilitation (CR)
Diagnosis of primary cervical esophageal cancer.
Presence of unstable angina.
Recipient of heart transplant.
Patient on cardiac transplant list or has a ventricular assist device
Patient's baseline weight > 300 lbs (due to weight limitations of the scale and bioelectrical impedance device)
Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within 14 days of study entry.
Other medical comorbidities that make the patient unable to participate in the CR program or other assessments involved with this study.

Study is for people with:

Breast Cancer

Estimated Enrollment:

20

Study ID:

NCT04072393

Recruitment Status:

Recruiting

Sponsor:

Washington University School of Medicine

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Washington University School of Medicine
Saint Louis Missouri, 63110, United States More Info
Shahed Badiyan, M.D.
Contact
314-273-2931
[email protected]
Shahed Badiyan, M.D.
Principal Investigator
Linda R Peterson, M.D.
Sub-Investigator
Joshua Mitchell, M.D.
Sub-Investigator
Cliff G Robinson, M.D.
Sub-Investigator
Matthew Spraker, MD., Ph.D.
Sub-Investigator
Aadel Chaudhuri, M.D., Ph.D.
Sub-Investigator
Greg Vlacich, M.D., Ph.D.
Sub-Investigator
Carmen Bergom, M.D., Ph.D.
Sub-Investigator
Yi Huang, Ph.D.
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

20

Study ID:

NCT04072393

Recruitment Status:

Recruiting

Sponsor:


Washington University School of Medicine

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.